Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

383 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Thyroid carcinoma.
Sherman SI, Angelos P, Ball DW, Beenken SW, Byrd D, Clark OH, Daniels GH, Dilawari RA, Ehya H, Farrar WB, Gagel RF, Kandeel F, Kloos RT, Kopp P, Lamonica DM, Loree TR, Lydiatt WM, McCaffrey J, Olson JA Jr, Ridge JA, Robbins R, Shah JP, Sisson JC, Thompson NW; National Comprehensive Cancer Network. Sherman SI, et al. Among authors: mccaffrey j. J Natl Compr Canc Netw. 2005 May;3(3):404-57. doi: 10.6004/jnccn.2005.0021. J Natl Compr Canc Netw. 2005. PMID: 16002006 No abstract available.
Thyroid carcinoma.
Tuttle RM, Ball DW, Byrd D, Dilawari RA, Doherty GM, Duh QY, Ehya H, Farrar WB, Haddad RI, Kandeel F, Kloos RT, Kopp P, Lamonica DM, Loree TR, Lydiatt WM, McCaffrey JC, Olson JA Jr, Parks L, Ridge JA, Shah JP, Sherman SI, Sturgeon C, Waguespack SG, Wang TN, Wirth LJ; National Comprehensive Cancer Network. Tuttle RM, et al. Among authors: mccaffrey jc. J Natl Compr Canc Netw. 2010 Nov;8(11):1228-74. doi: 10.6004/jnccn.2010.0093. J Natl Compr Canc Netw. 2010. PMID: 21081783 No abstract available.
Thyroid carcinoma.
Sherman SI, Angelos P, Ball DW, Byrd D, Clark OH, Daniels GH, Dilawari RA, Ehya H, Farrar WB, Gagel RF, Kandeel F, Kloos RT, Kopp P, Lamonica DM, Loree TR, Lydiatt WM, McCaffrey J, Olson JA Jr, Ridge JA, Shah JP, Sisson JC, Tuttle RM, Urist MM; National Comprehensive Cancer Network Thyroid Carcinoma Panel. Sherman SI, et al. Among authors: mccaffrey j. J Natl Compr Canc Netw. 2007 Jul;5(6):568-621. doi: 10.6004/jnccn.2007.0052. J Natl Compr Canc Netw. 2007. PMID: 17623612 No abstract available.
Medullary carcinoma.
Tuttle RM, Ball DW, Byrd D, Daniels GH, Dilawari RA, Doherty GM, Duh QY, Ehya H, Farrar WB, Haddad RI, Kandeel F, Kloos RT, Kopp P, Lamonica DM, Loree TR, Lydiatt WM, McCaffrey J, Olson JA Jr, Parks L, Ridge JA, Shah JP, Sherman SI, Sturgeon C, Waguespack SG, Wang TN, Wirth LJ; National Comprehensive Cancer Network. Tuttle RM, et al. Among authors: mccaffrey j. J Natl Compr Canc Netw. 2010 May;8(5):512-30. doi: 10.6004/jnccn.2010.0040. J Natl Compr Canc Netw. 2010. PMID: 20495082 No abstract available.
Thyroid carcinoma, version 2.2014.
Tuttle RM, Haddad RI, Ball DW, Byrd D, Dickson P, Duh QY, Ehya H, Haymart M, Hoh C, Hunt JP, Iagaru A, Kandeel F, Kopp P, Lamonica DM, Lydiatt WM, McCaffrey J, Moley JF, Parks L, Raeburn CD, Ridge JA, Ringel MD, Scheri RP, Shah JP, Sherman SI, Sturgeon C, Waguespack SG, Wang TN, Wirth LJ, Hoffmann KG, Hughes M. Tuttle RM, et al. Among authors: mccaffrey j. J Natl Compr Canc Netw. 2014 Dec;12(12):1671-80; quiz 1680. doi: 10.6004/jnccn.2014.0169. J Natl Compr Canc Netw. 2014. PMID: 25505208
Anaplastic Thyroid Carcinoma, Version 2.2015.
Haddad RI, Lydiatt WM, Ball DW, Busaidy NL, Byrd D, Callender G, Dickson P, Duh QY, Ehya H, Haymart M, Hoh C, Hunt JP, Iagaru A, Kandeel F, Kopp P, Lamonica DM, McCaffrey JC, Moley JF, Parks L, Raeburn CD, Ridge JA, Ringel MD, Scheri RP, Shah JP, Smallridge RC, Sturgeon C, Wang TN, Wirth LJ, Hoffmann KG, Hughes M. Haddad RI, et al. Among authors: mccaffrey jc. J Natl Compr Canc Netw. 2015 Sep;13(9):1140-50. doi: 10.6004/jnccn.2015.0139. J Natl Compr Canc Netw. 2015. PMID: 26358798 Free PMC article.
A phase 2 trial of lenvatinib (E7080) in advanced, progressive, radioiodine-refractory, differentiated thyroid cancer: A clinical outcomes and biomarker assessment.
Cabanillas ME, Schlumberger M, Jarzab B, Martins RG, Pacini F, Robinson B, McCaffrey JC, Shah MH, Bodenner DL, Topliss D, Andresen C, O'Brien JP, Ren M, Funahashi Y, Allison R, Elisei R, Newbold K, Licitra LF, Sherman SI, Ball DW. Cabanillas ME, et al. Cancer. 2015 Aug 15;121(16):2749-56. doi: 10.1002/cncr.29395. Epub 2015 Apr 24. Cancer. 2015. PMID: 25913680 Free PMC article. Clinical Trial.
A Phase II Trial of the Multitargeted Tyrosine Kinase Inhibitor Lenvatinib (E7080) in Advanced Medullary Thyroid Cancer.
Schlumberger M, Jarzab B, Cabanillas ME, Robinson B, Pacini F, Ball DW, McCaffrey J, Newbold K, Allison R, Martins RG, Licitra LF, Shah MH, Bodenner D, Elisei R, Burmeister L, Funahashi Y, Ren M, O'Brien JP, Sherman SI. Schlumberger M, et al. Among authors: mccaffrey j. Clin Cancer Res. 2016 Jan 1;22(1):44-53. doi: 10.1158/1078-0432.CCR-15-1127. Epub 2015 Aug 26. Clin Cancer Res. 2016. PMID: 26311725 Clinical Trial.
383 results